|
NR 4-6/2005
|
|
|
|
|
|
|
|
|
Miejsce analogów
prostaglandyn w farmakoterapii jaskry – stan obecny
The present role of
prostaglandin analogues in the medical treatment of glaucoma
Joanna Wierzbowska, Marek Rękas, Daria
Malawko
Z Kliniki Okulistyki Wojskowego Instytutu Medycznego w Warszawie
Kierownik: prof. dr hab. n. med. Andrzej Stankiewicz |
|
|
| Summary: |
Therapy with prostaglandin
analogues (PGA), a novel class of intraocular-lowering
medications, represents a safe and very effective
pharmacologic method of treating patients with glaucoma
and ocular hypertension. The convince dosing regimen,
once-daily, higher efficacy and higher systemic safety
profile seen with PGA compared with beta-blockers caused
that these agents have been approved by regulatory
bodies for both the first-line and adjunctive therapy.
Short, retrospective analysis of the medical treatment
of glaucoma in the Ophthalmology Clinic of Military
Health Service Institute in Warsaw, in 2003-2004, was
presented. |
| Słowa kluczowe: |
farmakoterapia jaskry, lek
pierwszego rzutu, terapia skojarzona, analogi
prostaglandyn, bezpieczeństwo terapii |
| Key words: |
the medical treatment of
glaucoma, the first-line therapy, the adjunctive
therapy, prostaglandin analogues, safety profile of the
treatment. |
|
|
|
|
|
|
